T. Kaneda et al., THE DIFFERENCE IN THE INHIBITORY MECHANISMS OF PAPAVERINE ON VASCULARAND INTESTINAL SMOOTH MUSCLES, European journal of pharmacology, 355(2-3), 1998, pp. 149-157
Papaverine (0.3-100 mu M) more potently inhibited phenylephrine (1 mu
M)-induced contraction than 65 mM K+-induced contraction of the aorta,
while it equally inhibited contractions induced by 65 mM K+ and carba
chol (1 mu M) in ileal smooth muscle. In phenylephrine-treated aorta,
papaverine (1-10 mu M) increased the cAMP and cGMP content. However, i
n carbachol-treated ileum, 30 mu M papaverine partially increased the
cAMP content while it maximally relaxed the preparation. In fura2-load
ed aorta, papaverine (0.3-10 mu M) inhibited both the contraction and
the increase in intracellular Ca2+ level ([Ca2+](i)) induced by phenyl
ephrine in parallel. However, papaverine inhibited carbachol-induced c
ontraction with only a small decrease in [Ca2+](i). Papaverine (1-30 m
u M) inhibited the carbachol-induced increase in oxidized flavoprotein
s, an indicator of increased mitochondrial oxidative phosphorylation,
in ileal smooth muscle whereas it did not change the phenylephrine-ind
uced increase in the aorta. These results suggest that papaverine inhi
bits smooth muscle contraction mainly by the accumulation of cAMP and/
or cGMP due to the inhibition of phosphodiesterase in the aorta wherea
s, in ileal smooth muscle, papaverine inhibits smooth muscle contracti
on mainly by the inhibition of mitochondrial respiration. (C) 1998 Els
evier Science B.V. All rights reserved.